IJU case reports · 2026
Bladder Perforation Following Transurethral Resection of Bladder Tumor With Immediate Intravesical Instillation of Epirubicin.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Abe Junya, Sawada Atsuro, Onizuka Chie, Akioka Takahiro, Nakai Naoko, Kojima Shimpei, Sakamoto Hiroki, Horinouchi Tomoya, Kamoto Toshiyuki
Аннотация
INTRODUCTION: Immediate postoperative intravesical chemotherapy following transurethral resection of bladder tumor (TURBT) is the standard procedure aimed at reducing recurrence.
CASE PRESENTATION: An 84-year-old man was diagnosed with an incidental 13-mm intravesical tumor during screening for biochemical recurrence following radiation therapy for prostate cancer. Accordingly, he underwent TURBT, followed by immediate postoperative intravesical chemotherapy with epirubicin. On postoperative day 2, he developed abdominal pain. Computed tomography demonstrated bladder perforation accompanied by retroperitoneal free air. He was diagnosed with extraperitoneal bladder perforation and thus managed with urethral catheterization; however, conservative treatment failed. Consequently, surgical repair with debridement was performed. Pale whitish granulation tissue was observed within the perivesical fat, suggesting epirubicin extravasation. Subsequently, cystography performed 28 days after bladder repair showed no contrast extravasation.
CONCLUSIONS: Surgical treatment should be considered as a potential treatment option for patients with suspected chemotherapy extravasation in whom conservative management is unsuccessful.
CASE PRESENTATION: An 84-year-old man was diagnosed with an incidental 13-mm intravesical tumor during screening for biochemical recurrence following radiation therapy for prostate cancer. Accordingly, he underwent TURBT, followed by immediate postoperative intravesical chemotherapy with epirubicin. On postoperative day 2, he developed abdominal pain. Computed tomography demonstrated bladder perforation accompanied by retroperitoneal free air. He was diagnosed with extraperitoneal bladder perforation and thus managed with urethral catheterization; however, conservative treatment failed. Consequently, surgical repair with debridement was performed. Pale whitish granulation tissue was observed within the perivesical fat, suggesting epirubicin extravasation. Subsequently, cystography performed 28 days after bladder repair showed no contrast extravasation.
CONCLUSIONS: Surgical treatment should be considered as a potential treatment option for patients with suspected chemotherapy extravasation in whom conservative management is unsuccessful.